BiotechTube

buntanetap/posiphen + Placebo

Phase 3Recruiting
0 watching 0 views this week๐Ÿ“ˆ Rising
69
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Early Alzheimers Disease

Conditions

Early Alzheimers Disease

Trial Timeline

Feb 4, 2025 โ†’ Jun 1, 2028

NCT ID
NCT06709014

About buntanetap/posiphen + Placebo

buntanetap/posiphen + Placebo is a phase 3 stage product being developed by Annovis Bio for Early Alzheimers Disease. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06709014. Target conditions include Early Alzheimers Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT06709014Phase 3Recruiting
NCT05686044Phase 2/3Completed
NCT05357989Phase 3Completed

Competing Products

20 competing products in Early Alzheimers Disease

See all competitors
ProductCompanyStageHype Score
50 mg PTI-125 + 100 mg PTI-125 + 200 mg PTI-125Cassava SciencesPhase 1
25
Anastrozole + Trastuzumab DeruxtecanDaiichi SankyoPhase 2
52
Fezolinetant + PlaceboAstellas PharmaPhase 2
52
Lecanemab IV + Placebo + Lecanemab SCEisaiPhase 3
77
E2609EisaiPhase 1
33
Doxorubicin + Cyclophosphamide + Taxane + Letrozole + Abemaciclib + LHRH AnalogueEli LillyPhase 2
52
PERT-IJS plus trastuzumab, carboplatin and docetaxel + Perjeta plus trastuzumab, carboplatin and docetaxelBioconPhase 3
77
ICGJohnson & JohnsonPre-clinical
23
SHR-A1811 for Injection + Docetaxel injection + Trastuzumab Injection + Carboplatin for Injection + Pertuzumab InjectionJiangsu Hengrui MedicinePhase 3
77
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR7280 tabletsJiangsu Hengrui MedicinePhase 2
52
SHR7280๏ผ›Ganirelix Acetate Injection simulant + SHR7280 simulant๏ผ› Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
77
Nab-paclitaxel in combination with pyrotinibJiangsu Hengrui MedicinePhase 2
52
Adalimumab + Methotrexate + Adalimumab placebo + Methotrexate placeboAbbViePhase 3
77
adalimumab + methotrexateAbbViePhase 3
77
Camizestrant + Tamoxifen + Anastrozole + Letrozole + ExemestaneAstraZenecaPhase 3
77
Camizestrant + Tamoxifen + Anastrozole + Letrozole + Exemestane + AbemaciclibAstraZenecaPhase 3
77
Tamoxifen alone + Tamoxifen + AminoglutethimideAstraZenecaPhase 3
77
Cyclophosphamide + Methotrexate + Fluorouracil implant + Goserelin + TamoxifenAstraZenecaPhase 3
77
Trastuzumab deruxtecan + Standard-of-CareAstraZenecaPhase 2
52

Other Products from Annovis Bio

buntanetap/posiphen + PlaceboPhase 3
69
Buntanetap/Posiphen + PlaceboPhase 2/3
57
buntanetap/posiphenPhase 2/3
57
Posiphen + PlaceboPhase 1/2
33
Posiphen + PlaceboPhase 1/2
33